Pancreas duct abnormalities in patients with ulcerative colitis: A magnetic resonance pancreatography study

Inflammatory Bowel Diseases

Volumn 11, Issue 10, 2005, Pages 903-908

  Toda, Nobuo ^a,b,d   Akahane, Masaaki ^a   Kiryu, Shigeru ^a   Matsubara, Yasuo ^a   Yamaji, Yutaka ^a   Okamoto, Makoto ^a   Minagawa, Nobuyuki ^c   Ohgi, Kazuyuki ^c   Komatsu, Yutaka ^a   Yahagi, Naohisa ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Ohtomo, Kuni ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Magnetic resonance cholangiopancreatography; Pancreatitis; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; FEMALE; HUMAN; MAGNETIC RESONANCE PANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DUCT; PANCREAS MALFORMATION; PANCREATOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; COLITIS, ULCERATIVE; CONSTRICTION, PATHOLOGIC; CROSS-SECTIONAL STUDIES; DILATATION, PATHOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC DUCTS; PANCREATITIS, CHRONIC; PREVALENCE;

EID: 26444448456     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000183419.17563.17     Document Type: Article

References (26)

1. Barthet M, Hastier P, Bernard J, et al. Chrome pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroentrol. 1999;94:2141-2148.
2. Heikus B, Niemela S, Lehtola J, et al. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scand J Gastroenterol. 1997;32:153-161.
3. Lankish PG, Droge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995;37:565-567.
4. Deprez P, Descamps CH, Fiasse R. Pancreatitis induced by 5-amino-salicylic acid. Lancet. 1989;2:445-446.
5. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332:924-933.
6. Glaser J. Bildgebende Diagnostik bei Erkrankungen der Bauchspeicheldrüse. Dtsch Med Wochenschr. 1990;115:1361-1367.
7. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas. 1991;6:350-367.
8. Cohen SA, Siegel JH, Kasmin FE. Complications of diagnostic and therapeutic ERCP. Abdom Imaging. 1996;21:385-394.
9. Heikus B, Niemelä S, Lehtola J, et al. Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 1996;31:517-523.
10. Li Y, Chiverton SG, Hunt RH. Exocrine pancreatic function tests. A review. Can J Gastroenterol. 1989;3:153-161.
11. Ventrucci M, Pezzilli JH, Gullo L, et al. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci. 1989; 34:39-45.
12. Sica G, Braver J, Cooney M, et al. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis. Radiology. 1999;210:605-610.
13. Mirowitz SA, Gutierrez E, Lee JKT, et al. Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging. Radiology. 1991;180:637-640.
14. Hamed MM, Hamm B, Ibrahim ME, et al. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas. AJR Am J Roentgenol. 1992;158:303-307.
15. Wakabayashi T, Motto Y, Kojima Y, et al. Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci. 1998;43:2415-2425.
16. Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25:1107-1112.
17. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentration in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
18. Sica GT, Miller FH, Rodriguez G, et al. Magnetic resonance imaging in patients with pancreatitis: evaluation of signal intensity and enhancement changes. J Magn Reson Imaging. 2002;15:275-284.
19. Zhang XM, Shi H, Parker L, et al. Suspected early or mild chronic pancreatitis: Enhancement patterns on gadolinium chelate dynamic MRI. J Magn Reson Imaging. 2003;17:86-94.
20. Rasmussen HH, Fonager K, Sorensen HT, et al. Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study. Scand J Gastroenterol. 1999;34:199-201.
21. Sarles H, Sarles J-C, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-698.
22. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387-395.
23. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-1568.
24. Borkje B, Vetvik K, Odegaard S, et al. Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis. Scand J Gastroenterol. 1985;20:539-542.
25. Montefusco PP, Geiss AC, Bronzo RL, et al. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am J Surg. 1984;147:822-826.
26. Epstein O, Chapman RW, Lake-Bakaar G, et al. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology. 1982;83:1177-1182.